Equity Overview
Price & Market Data
Price: $0.55
Daily Change: $0.00 / 0.00%
Daily Range: $0.55 - $0.55
Market Cap: $42,113,992
Daily Volume: 19,500
Performance Metrics
1 Week: 19.31%
1 Month: 4.17%
3 Months: -26.67%
6 Months: 30.95%
1 Year: 66.67%
YTD: 38.47%
Details
Gemina Laboratories Ltd., a biotechnology company, engages in the research, development, and commercialization of in-vitro diagnostics in Canada. The company's products include LEGIO X COVID-19, a COVID-19 rapid antigen test; and LEGIO X Influenza AB, an influenza AB multiplex lateral flow test. It also develops respiratory syncytial virus and tuberculosis. Gemina Laboratories Ltd. was incorporated in 2017 and is headquartered in Burnaby, Canada.